Demyelinating events in rheumatoid arthritis after drug exposures | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Clinical and epidemiological research

Concise report

Demyelinating events in rheumatoid arthritis after drug exposures

Authors

Sasha Bernatsky PubMed articles Google scholar articles
Christel Renoux PubMed articles Google scholar articles
Samy Suissa PubMed articles Google scholar articles

Correspondence to Samy Suissa, Centre for Clinical Epidemiology, Jewish General Hospital – Lady Davis Institute, 3755 Cote Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada; samy.suissa{at}mcgill.ca

Citation

Bernatsky S, Renoux C, Suissa S

Demyelinating events in rheumatoid arthritis after drug exposures

Annals of the Rheumatic Diseases 2010;69:1691-1693.

Publication history

Accepted June 27, 2009
First published July 23, 2009.

Online issue publication

April 09, 2023

Article Versions

Previous version (25 October 2017).
Previous version (25 October 2017).
Previous version (25 October 2017).
You are viewing the most recent version of this article.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions